Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% during mid-day trading on Wednesday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8 %
The stock has a market cap of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The business has a fifty day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58. The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to invest in marijuana stocks in 7 steps
- 3 Penny Stocks Ready to Break Out in 2025
- How to Read Stock Charts for Beginners
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
